Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin MR add-on to metformin in type 2 diabetes
2008-004722-16Phase 2Completed
- Sponsor
- Novartis
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of vildagliptin in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Novartis. Primary endpoint: Change from baseline in HbA1c at Week 24. Started Oct 2008; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-004722-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004722-16.